{"transactions":[{"id":4635451,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-03T00:43:49.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":3662,"price":3.14,"value":11498.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 1, 2026."}],"balance_after":75612,"source":{"system":"sec-edgar","filing":"0001470831-26-000925","document":"wk-form4_1790973827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000925/wk-form4_1790973827.xml","form_type":"4"}},{"id":717131,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-02T20:04:40.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":2650,"price":4.34,"value":11501.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2026."}],"balance_after":71950,"source":{"system":"sec-edgar","filing":"0001470831-26-000688","document":"wk-form4_1783022665.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000688/wk-form4_1783022665.xml","form_type":"4"}},{"id":725219,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-26T20:30:22.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":62000,"derivative":{"exercise_price":4.25,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001470831-26-000665","document":"wk-form4_1782505819.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000665/wk-form4_1782505819.xml","form_type":"4"}},{"id":749131,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-04T20:14:41.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":1070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents the exercise of a stock option for cash. No shares were sold in connection with the exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares underlying this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.11,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":1070},"source":{"system":"sec-edgar","filing":"0001470831-26-000504","document":"wk-form4_1780604078.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000504/wk-form4_1780604078.xml","form_type":"4"}},{"id":749130,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T20:14:41.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":1070,"price":2.11,"value":2257.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents the exercise of a stock option for cash. No shares were sold in connection with the exercise."}],"balance_after":69300,"source":{"system":"sec-edgar","filing":"0001470831-26-000504","document":"wk-form4_1780604078.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000504/wk-form4_1780604078.xml","form_type":"4"}},{"id":815528,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T14:45:54.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":4259,"price":2.7,"value":11499.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 1, 2026."}],"balance_after":68230,"source":{"system":"sec-edgar","filing":"0001470831-26-000346","document":"wk-form4_1775227552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000346/wk-form4_1775227552.xml","form_type":"4"}},{"id":949898,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-05T21:10:46.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":5958,"price":1.93,"value":11498.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 2, 2026."}],"balance_after":146532,"source":{"system":"sec-edgar","filing":"0001470831-26-000009","document":"wk-form4_1767647442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083126000009/wk-form4_1767647442.xml","form_type":"4"}},{"id":1024011,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:14:17.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":5349,"price":2.15,"value":11500.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 1, 2025."}],"balance_after":140574,"source":{"system":"sec-edgar","filing":"0001470831-25-000250","document":"wk-form4_1759522454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000147083125000250/wk-form4_1759522454.xml","form_type":"4"}},{"id":1094157,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T20:17:16.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":7616,"price":1.51,"value":11500.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2025."}],"balance_after":135225,"source":{"system":"sec-edgar","filing":"0001662579-25-000053","document":"wk-form4_1751487429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000053/wk-form4_1751487429.xml","form_type":"4"}},{"id":1104574,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:11:29.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":35500,"derivative":{"exercise_price":1.44,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001662579-25-000046","document":"wk-form4_1750450283.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000046/wk-form4_1750450283.xml","form_type":"4"}},{"id":1178699,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-03T20:11:41.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":7841,"price":1.435,"value":11251.835,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 1, 2025."}],"balance_after":127609,"source":{"system":"sec-edgar","filing":"0001662579-25-000024","document":"wk-form4_1743711094.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000024/wk-form4_1743711094.xml","form_type":"4"}},{"id":1313332,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T21:08:23.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":3074,"price":3.66,"value":11250.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 2, 2025."}],"balance_after":119768,"source":{"system":"sec-edgar","filing":"0001662579-25-000003","document":"wk-form4_1735938496.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257925000003/wk-form4_1735938496.xml","form_type":"4"}},{"id":1393671,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T20:32:27.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":2023,"price":5.56,"value":11247.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 1, 2024."}],"balance_after":116694,"source":{"system":"sec-edgar","filing":"0001662579-24-000089","document":"wk-form4_1727901140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257924000089/wk-form4_1727901140.xml","form_type":"4"}},{"id":1462035,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T20:12:59.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":2320,"price":4.85,"value":11252.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2024."}],"balance_after":114671,"source":{"system":"sec-edgar","filing":"0001662579-24-000063","document":"wk-form4_1719951170.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257924000063/wk-form4_1719951170.xml","form_type":"4"}},{"id":1471668,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T20:07:02.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 20, 2025 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":32500,"derivative":{"exercise_price":4.05,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001662579-24-000055","document":"wk-form4_1719000414.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257924000055/wk-form4_1719000414.xml","form_type":"4"}},{"id":1552615,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-02T20:35:32.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":1389,"price":8.1,"value":11250.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 1, 2024."}],"balance_after":112351,"source":{"system":"sec-edgar","filing":"0001662579-24-000038","document":"wk-form4_1712090101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257924000038/wk-form4_1712090101.xml","form_type":"4"}},{"id":1690730,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-03T21:11:41.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":1725,"price":6.52,"value":11247.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 2, 2024."}],"balance_after":110962,"source":{"system":"sec-edgar","filing":"0001662579-24-000005","document":"wk-form4_1704316284.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257924000005/wk-form4_1704316284.xml","form_type":"4"}},{"id":1766503,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-03T20:28:08.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":6617,"price":1.7,"value":11248.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 2, 2023."}],"balance_after":109237,"source":{"system":"sec-edgar","filing":"0001662579-23-000109","document":"wk-form4_1696364878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000109/wk-form4_1696364878.xml","form_type":"4"}},{"id":1835090,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-05T20:25:30.000Z","date":"2023-07-03","kind":"grant","planned":false,"acquired":true,"shares":3976,"price":2.83,"value":11252.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 3, 2023."}],"balance_after":102620,"source":{"system":"sec-edgar","filing":"0001662579-23-000068","document":"wk-form4_1688588720.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000068/wk-form4_1688588720.xml","form_type":"4"}},{"id":1851290,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T20:25:55.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2024 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":26000,"derivative":{"exercise_price":3.61,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001662579-23-000062","document":"wk-form4_1686947141.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000062/wk-form4_1686947141.xml","form_type":"4"}},{"id":1926678,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T20:19:31.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":3516,"price":3.2,"value":11251.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 3, 2023."}],"balance_after":98644,"source":{"system":"sec-edgar","filing":"0001662579-23-000045","document":"wf-form4_168063954562598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000045/wf-form4_168063954562598.xml","form_type":"4"}},{"id":2059817,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T21:55:22.000Z","date":"2023-01-06","kind":"exercise","acquired":false,"shares":444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option vest and become exercisable in 12 equal quarterly installments, with the first installment vested on October 1, 2020."}],"balance_after":890,"derivative":{"exercise_price":4.98,"expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":444},"source":{"system":"sec-edgar","filing":"0001662579-23-000008","document":"wf-form4_167304210044893.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000008/wf-form4_167304210044893.xml","form_type":"4"}},{"id":2059816,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T21:55:22.000Z","date":"2023-01-06","kind":"exercise","acquired":false,"shares":268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"12.5% of the shares underlying this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter."}],"balance_after":1067,"derivative":{"exercise_price":2.11,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":268},"source":{"system":"sec-edgar","filing":"0001662579-23-000008","document":"wf-form4_167304210044893.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000008/wf-form4_167304210044893.xml","form_type":"4"}},{"id":2059815,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-06T21:55:22.000Z","date":"2023-01-06","kind":"exercise","acquired":true,"shares":444,"price":4.98,"value":2211.12,"ownership":{"direct":true},"balance_after":95128,"source":{"system":"sec-edgar","filing":"0001662579-23-000008","document":"wf-form4_167304210044893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000008/wf-form4_167304210044893.xml","form_type":"4"}},{"id":2059814,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-06T21:55:22.000Z","date":"2023-01-06","kind":"exercise","acquired":true,"shares":268,"price":2.11,"value":565.48,"ownership":{"direct":true},"balance_after":94684,"source":{"system":"sec-edgar","filing":"0001662579-23-000008","document":"wf-form4_167304210044893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000008/wf-form4_167304210044893.xml","form_type":"4"}},{"id":2065522,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T21:17:42.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1568,"price":6.38,"value":10003.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 3, 2023."}],"balance_after":94416,"source":{"system":"sec-edgar","filing":"0001662579-23-000006","document":"wf-form4_167286703601250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257923000006/wf-form4_167286703601250.xml","form_type":"4"}},{"id":2143587,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T22:05:26.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares underlying this option vest and become exercisable in 12 equal quarterly installments, with the first installment vested on October 1, 2020."}],"balance_after":1334,"derivative":{"exercise_price":4.98,"expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":445},"source":{"system":"sec-edgar","filing":"0001662579-22-000004","document":"wf-form4_166492110095346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257922000004/wf-form4_166492110095346.xml","form_type":"4"}},{"id":2143586,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T22:05:26.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":267,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"12.5% of the shares underlying this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter."}],"balance_after":1335,"derivative":{"exercise_price":2.11,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":267},"source":{"system":"sec-edgar","filing":"0001662579-22-000004","document":"wf-form4_166492110095346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257922000004/wf-form4_166492110095346.xml","form_type":"4"}},{"id":2143585,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-04T22:05:26.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":1150,"price":8.69,"value":9993.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 3, 2022."}],"balance_after":92848,"source":{"system":"sec-edgar","filing":"0001662579-22-000004","document":"wf-form4_166492110095346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257922000004/wf-form4_166492110095346.xml","form_type":"4"}},{"id":2143584,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-04T22:05:26.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":445,"price":4.98,"value":2216.1,"ownership":{"direct":true},"balance_after":91698,"source":{"system":"sec-edgar","filing":"0001662579-22-000004","document":"wf-form4_166492110095346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257922000004/wf-form4_166492110095346.xml","form_type":"4"}},{"id":2143583,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-04T22:05:26.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":267,"price":2.11,"value":563.37,"ownership":{"direct":true},"balance_after":91253,"source":{"system":"sec-edgar","filing":"0001662579-22-000004","document":"wf-form4_166492110095346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000166257922000004/wf-form4_166492110095346.xml","form_type":"4"}},{"id":2206146,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-18T21:18:38.000Z","date":"2022-07-15","kind":"exercise","acquired":false,"shares":889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option vest and become exercisable in 12 equal quarterly installments, with the first installment vested on October 1, 2020."}],"balance_after":1779,"derivative":{"exercise_price":4.98,"expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":889},"source":{"system":"sec-edgar","filing":"0001209191-22-042457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122042457/doc4.xml","form_type":"4"}},{"id":2206145,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-18T21:18:38.000Z","date":"2022-07-15","kind":"exercise","acquired":false,"shares":535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"12.5% of the shares underlying this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter."}],"balance_after":1602,"derivative":{"exercise_price":2.11,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":535},"source":{"system":"sec-edgar","filing":"0001209191-22-042457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122042457/doc4.xml","form_type":"4"}},{"id":2206144,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-18T21:18:38.000Z","date":"2022-07-15","kind":"exercise","acquired":true,"shares":889,"price":4.98,"value":4427.22,"ownership":{"direct":true},"balance_after":90986,"source":{"system":"sec-edgar","filing":"0001209191-22-042457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122042457/doc4.xml","form_type":"4"}},{"id":2206143,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-18T21:18:38.000Z","date":"2022-07-15","kind":"exercise","acquired":true,"shares":535,"price":2.11,"value":1128.85,"ownership":{"direct":true},"balance_after":90097,"source":{"system":"sec-edgar","filing":"0001209191-22-042457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122042457/doc4.xml","form_type":"4"}},{"id":2213896,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-05T20:11:49.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":1246,"price":8.03,"value":10005.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2022."}],"balance_after":89562,"source":{"system":"sec-edgar","filing":"0001209191-22-040597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122040597/doc4.xml","form_type":"4"}},{"id":2222701,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-23T20:16:17.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 22, 2023 and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":23500,"derivative":{"exercise_price":6.06,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001209191-22-038865","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122038865/doc4.xml","form_type":"4"}},{"id":2303405,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T20:25:33.000Z","date":"2022-04-04","kind":"grant","acquired":true,"shares":341,"price":26.46,"value":9022.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 4, 2022."}],"balance_after":88316,"source":{"system":"sec-edgar","filing":"0001209191-22-023016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122023016/doc4.xml","form_type":"4"}},{"id":2424872,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-26T22:26:13.000Z","date":"2022-01-26","kind":"exercise","acquired":false,"shares":1334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this option vest and become exercisable in 12 equal quarterly installments, with the first installment vested on October 1, 2020."}],"balance_after":2668,"derivative":{"exercise_price":4.98,"expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":1334},"source":{"system":"sec-edgar","filing":"0001209191-22-005107","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122005107/doc4.xml","form_type":"4"}},{"id":2424871,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-26T22:26:13.000Z","date":"2022-01-26","kind":"exercise","acquired":false,"shares":803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"12.5% of the shares underlying this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter."}],"balance_after":2137,"derivative":{"exercise_price":2.11,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":803},"source":{"system":"sec-edgar","filing":"0001209191-22-005107","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122005107/doc4.xml","form_type":"4"}},{"id":2424870,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-26T22:26:13.000Z","date":"2022-01-26","kind":"exercise","acquired":true,"shares":1334,"price":4.98,"value":6643.32,"ownership":{"direct":true},"balance_after":87975,"source":{"system":"sec-edgar","filing":"0001209191-22-005107","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122005107/doc4.xml","form_type":"4"}},{"id":2424869,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-26T22:26:13.000Z","date":"2022-01-26","kind":"exercise","acquired":true,"shares":803,"price":2.11,"value":1694.33,"ownership":{"direct":true},"balance_after":86641,"source":{"system":"sec-edgar","filing":"0001209191-22-005107","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122005107/doc4.xml","form_type":"4"}},{"id":2433347,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-18T21:30:22.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":278,"price":31.58,"value":8779.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 4, 2022."}],"balance_after":85838,"source":{"system":"sec-edgar","filing":"0001209191-22-003500","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919122003500/doc4.xml","form_type":"4"}},{"id":2547863,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T20:53:33.000Z","date":"2021-10-04","kind":"grant","acquired":true,"shares":194,"price":44.99,"value":8728.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 4, 2021."}],"balance_after":85560,"source":{"system":"sec-edgar","filing":"0001209191-21-059515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121059515/doc4.xml","form_type":"4"}},{"id":2639029,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-07T20:30:22.000Z","date":"2021-07-02","kind":"grant","acquired":true,"shares":220,"price":39.72,"value":8738.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 2, 2021."}],"balance_after":85366,"source":{"system":"sec-edgar","filing":"0001209191-21-045806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121045806/doc4.xml","form_type":"4"}},{"id":2662766,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T20:15:57.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2022 and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":23500,"derivative":{"exercise_price":37.66,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001209191-21-041427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121041427/doc4.xml","form_type":"4"}},{"id":2749218,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-14T20:39:48.000Z","date":"2021-04-14","kind":"exercise","acquired":false,"shares":444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Represents underlying unexercised options that were granted on July 3, 2020. The terms of the original grant provide that this option shall vest and become exercisable in 12 equal quarterly installments, with the first installment vested on October 1, 2020."}],"balance_after":4002,"derivative":{"exercise_price":4.98,"expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":444},"source":{"system":"sec-edgar","filing":"0001209191-21-026665","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121026665/doc4.xml","form_type":"4"}},{"id":2749217,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-14T20:39:48.000Z","date":"2021-04-14","kind":"exercise","acquired":false,"shares":267,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 12.5% of this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter."}],"balance_after":2940,"derivative":{"exercise_price":2.11,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":267},"source":{"system":"sec-edgar","filing":"0001209191-21-026665","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121026665/doc4.xml","form_type":"4"}},{"id":2749216,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-14T20:39:48.000Z","date":"2021-04-14","kind":"exercise","acquired":true,"shares":444,"price":4.98,"value":2211.12,"ownership":{"direct":true},"balance_after":85146,"source":{"system":"sec-edgar","filing":"0001209191-21-026665","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121026665/doc4.xml","form_type":"4"}},{"id":2749215,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-14T20:39:48.000Z","date":"2021-04-14","kind":"exercise","acquired":true,"shares":267,"price":2.11,"value":563.37,"ownership":{"direct":true},"balance_after":84702,"source":{"system":"sec-edgar","filing":"0001209191-21-026665","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121026665/doc4.xml","form_type":"4"}},{"id":2749214,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-14T20:39:48.000Z","date":"2021-04-13","kind":"gift","acquired":true,"shares":2278,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On April 13, 2021, Cynthia E. Anderson received a distribution of 2,278 shares of the Issuer's common stock from the Cynthia E. Anderson 2016 Grantor Retained Annuity Trust."}],"balance_after":47316,"source":{"system":"sec-edgar","filing":"0001209191-21-026665","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121026665/doc4.xml","form_type":"4"}},{"id":2749213,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-14T20:39:48.000Z","date":"2021-04-13","kind":"gift","acquired":true,"shares":2278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 13, 2021, Kenneth C. Anderson received a distribution of 2,278 shares of the Issuer's common stock from the Kenneth C. Anderson 2016 Grantor Retained Annuity Trust."}],"balance_after":84435,"source":{"system":"sec-edgar","filing":"0001209191-21-026665","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121026665/doc4.xml","form_type":"4"}},{"id":2755334,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-06T20:31:07.000Z","date":"2021-04-05","kind":"grant","acquired":true,"shares":233,"price":37.51,"value":8739.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 5, 2021."}],"balance_after":82157,"source":{"system":"sec-edgar","filing":"0001209191-21-025665","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121025665/doc4.xml","form_type":"4"}},{"id":2894728,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-26T21:34:06.000Z","date":"2021-01-22","kind":"exercise","acquired":false,"shares":889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option shall vest and become exercisable in 12 equal quarterly installments, with the first installment vesting on October 1, 2020."}],"balance_after":4446,"derivative":{"exercise_price":4.98,"expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":889},"source":{"system":"sec-edgar","filing":"0001209191-21-005374","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121005374/doc4.xml","form_type":"4"}},{"id":2894727,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-26T21:34:06.000Z","date":"2021-01-22","kind":"exercise","acquired":false,"shares":121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"The Form 3 filed on October 1, 2020 included an incorrect number of underlying securities in Table II, Column 3 (118)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 20% of this option vested and became exercisable on January 1, 2017, with the remainder vesting in 16 equal quarterly installments thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"The Form 3 filed on October 1, 2020 included an incorrect number of underlying securities in Table II, Column 3 (118)."}],"balance_after":0,"derivative":{"exercise_price":2.11,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":121},"source":{"system":"sec-edgar","filing":"0001209191-21-005374","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121005374/doc4.xml","form_type":"4"}},{"id":2894726,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-26T21:34:06.000Z","date":"2021-01-22","kind":"exercise","acquired":false,"shares":538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 12.5% of this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter."}],"balance_after":3207,"derivative":{"exercise_price":2.11,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":538},"source":{"system":"sec-edgar","filing":"0001209191-21-005374","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121005374/doc4.xml","form_type":"4"}},{"id":2894725,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-26T21:34:06.000Z","date":"2021-01-22","kind":"exercise","acquired":true,"shares":889,"price":4.98,"value":4427.22,"ownership":{"direct":true},"balance_after":81924,"source":{"system":"sec-edgar","filing":"0001209191-21-005374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121005374/doc4.xml","form_type":"4"}},{"id":2894724,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-26T21:34:06.000Z","date":"2021-01-22","kind":"exercise","acquired":true,"shares":121,"price":2.11,"value":255.31,"ownership":{"direct":true},"balance_after":81035,"source":{"system":"sec-edgar","filing":"0001209191-21-005374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121005374/doc4.xml","form_type":"4"}},{"id":2894723,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-26T21:34:06.000Z","date":"2021-01-22","kind":"exercise","acquired":true,"shares":538,"price":2.11,"value":1135.18,"ownership":{"direct":true},"balance_after":80914,"source":{"system":"sec-edgar","filing":"0001209191-21-005374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000120919121005374/doc4.xml","form_type":"4"}},{"id":3011357,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-10-07T01:27:56.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":142857,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Cynthia E. Anderson 2015 Irrevocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by the Cynthia E. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16939},"source":{"system":"sec-edgar","filing":"0000899243-20-027696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000089924320027696/doc4.xml","form_type":"4"}},{"id":3011356,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-10-07T01:27:56.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":142857,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Kenneth C. Anderson 2015 Irrevocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by the Kenneth C. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16939},"source":{"system":"sec-edgar","filing":"0000899243-20-027696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000089924320027696/doc4.xml","form_type":"4"}},{"id":3011355,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-10-07T01:27:56.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":347840,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Cynthia E. Anderson 2016 Grantor Retained Annuity Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held the Cynthia E. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":41244},"source":{"system":"sec-edgar","filing":"0000899243-20-027696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000089924320027696/doc4.xml","form_type":"4"}},{"id":3011354,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-10-07T01:27:56.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":347840,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Kenneth C. Anderson 2016 Grantor Retained Annuity Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the Kenneth C. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":41244},"source":{"system":"sec-edgar","filing":"0000899243-20-027696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000089924320027696/doc4.xml","form_type":"4"}},{"id":3011353,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-10-07T01:27:56.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":152160,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18040},"source":{"system":"sec-edgar","filing":"0000899243-20-027696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000089924320027696/doc4.xml","form_type":"4"}},{"id":3011352,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-10-07T01:27:56.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":152160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18040},"source":{"system":"sec-edgar","filing":"0000899243-20-027696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000089924320027696/doc4.xml","form_type":"4"}},{"id":3011351,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-07T01:27:56.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":16939,"ownership":{"direct":false,"nature":"By Cynthia E. Anderson 2015 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by the Cynthia E. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":16939,"source":{"system":"sec-edgar","filing":"0000899243-20-027696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000089924320027696/doc4.xml","form_type":"4"}},{"id":3011350,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-07T01:27:56.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":16939,"ownership":{"direct":false,"nature":"By Kenneth C. Anderson 2015 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by the Kenneth C. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":16939,"source":{"system":"sec-edgar","filing":"0000899243-20-027696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000089924320027696/doc4.xml","form_type":"4"}},{"id":3011349,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-07T01:27:56.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":41244,"ownership":{"direct":false,"nature":"By Cynthia E. Anderson 2016 Grantor Retained Annuity Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held the Cynthia E. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":63543,"source":{"system":"sec-edgar","filing":"0000899243-20-027696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000089924320027696/doc4.xml","form_type":"4"}},{"id":3011348,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-07T01:27:56.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":41244,"ownership":{"direct":false,"nature":"By Kenneth C. Anderson 2016 Grantor Retained Annuity Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the Kenneth C. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":63543,"source":{"system":"sec-edgar","filing":"0000899243-20-027696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000089924320027696/doc4.xml","form_type":"4"}},{"id":3011347,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-07T01:27:56.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":18040,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."}],"balance_after":45038,"source":{"system":"sec-edgar","filing":"0000899243-20-027696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000089924320027696/doc4.xml","form_type":"4"}},{"id":3011346,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-07T01:27:56.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":18040,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."}],"balance_after":80376,"source":{"system":"sec-edgar","filing":"0000899243-20-027696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000089924320027696/doc4.xml","form_type":"4"}},{"id":3012388,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":32615,"kind":"person","name":"Anderson Kenneth Carl","position":1,"cik":"0001824862","reported_name":"Anderson Kenneth Carl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-06T01:00:08.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable upon the earlier to occur of (i) October 1, 2021, and (ii) the next annual meeting of the Issuer's stockholders"}],"balance_after":17786,"derivative":{"exercise_price":19,"expiration_date":"2030-09-30","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0000899243-20-027443","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662579/000089924320027443/doc4.xml","form_type":"4"}}]}